Avacta Group

AVCT: 20.25 0.00 (0.00%) delayed: 19 Nov 2019, 5:00

Trade now

Avacta Group Fundamentals

Share Price Information

Name Avacta Group
Epic AVCT
Sector Biotechnology
ISIN GB00BYYW9G87
Activites Avacta Group plc's (formerly Readybuy plc) principal focus is on its proprietary Affimer technology which is a novel engineered alternative to antibodies that has wide application in Life Sciences for diagnostics, therapeutics and general research and development. Antibodies dominate markets worth in excess of $100bn despite their shortcomings. Affimer technology has been designed to address many of these negative performance issues, principally; the time taken to generate new antibodies, the reliance on an animal's immune response, poor specificity in many cases, and batch to batch variability. Affimer technology is based on a small protein that can be quickly generated to bind with high specificity and affinity to a wide range of protein targets. Avacta has a pre-clinical biotech development programme with an in-house focus on immuno-oncology as well as partnered development programmes. Avacta is commercialising non-therapeutic Affimer reagents through licensing to developers of life sciences research tools and diagnostics.
Index n/a

Key numbers

Latest Share price (p) 0.00 Net gearing (%) -16.40
Market capitalisation (£m) 35.19 Gross gearing (%) 8.90
Shares in issue (m) 175.94 Debt ratio 0.00
P/E ratio -2.28 Debt-to-equity ratio 0.00
Total dividends per share (p) 0.00 Assets / equity ratio 1.10
Dividend yield (%) 0.00 Price to book value 1.50
Dividend cover 0.00 ROCE (%) -47.48
Earning per share (p) -8.76 EPS growth (%) 35.06
52-week high / low (p) 49.00 / 15.13 DPS growth (%) n/a

Results at a glance

Date Type Turnover (£m) Profit (£m) Basic EPS Currency
31 Jul 2019 Full Year 4 -10 -8.76 GBP
31 Jul 2018 Full Year 3 -9 -13.49 GBP
31 Jul 2017 Full Year 3 -6 -9.31 GBP

Dividend history

Period Ex-date Pay-date Net dividend Currency Total for year

Contact details

Company name Avacta Group
Address Unit 20, Ash Way, Thorp Arch Estate, Wetherby LS23 7FA.
Telephone +44 (0)844 414 0452
Website http://www.avacta.com/

Advisors

Company's broker finnCap
Company's joint broker WG Partners
NOMAD finnCap
Registrar Link Asset Services
Auditors KPMG Audit
Solicitors Walker Morris

Directors

Appointed Director Position
07 Jul 2006 Prof David Alastair Maclaughlin Smith Chief Executive Officer
04 Jan 2016 Tony Peter Gardiner Chief Financial Officer
11 Jun 2018 Dr Eliot Richard Forster Non-Executive Chairman
28 Jan 2019 Dr Samuel Cameron Williams Non-Executive Director
17 Sep 2015 Dr Michael John Owen Non-Executive Director
05 Aug 2013 Dr Trevor John Nicholls Non-Executive Director

Company financials

Assets (£m) 2019 2018 2017
Reporting date 31 Jul 2019 31 Jul 2018 31 Jul 2017
Tangible assets 3 3 3
Intangible asssets and goodwill 13 12 12
Investments and other non-current assets 0 0 0
Total non-current assets 15 15 16
Inventory / work in progress 0 0 0
Trade and other receivables 2 1 1
Cash and equivalents 7 5 9
Other current assets and asset held for resale 2 2 5
Total of all assets 26 23 32
Liabilities (£m) 2019 2018 2017
Short term liabilities 2 2 2
Long term liabilities 0 0 0
Other liabilites / pension etc 0 0 0
Total of all liabilities 2 2 2
Net assets (£m) 2019 2018 2017
Net assets 23 21 30
Equity (£m) 2019 2018 2017
Share capital 12 7 7
Minority interests 0 0 0
Retained earnings 7 16 25
Share premium account 7 1 1
Other equity -3 -3 -2
Total equity 23 21 30
Cash Flow (£m) 2019 2018 2017
Cash from operating activities -8 -5 -4
Cashflow before financing -10 -4 -0
Increase / decrease in Cash 1 -4 -0
Income (£m) 2019 2018 2017
Turnover 4 3 3
Cost of sales 1 1 1
Gross profit 3 2 2
Operating profit -11 -10 -8
Pre-tax profit -11 -10 -8
Profit / loss for the year -10 -9 -6